# FDA Inspection 1204459 - South Florida Institute for Reproductive Medicine - April 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/south-florida-institute-for-reproductive-medicine/e04e047a-4cae-4825-94d3-4776b1937dfa
Source feed: FDA_Inspections

> FDA Inspection 1204459 for South Florida Institute for Reproductive Medicine on April 19, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204459
- Company Name: South Florida Institute for Reproductive Medicine
- Inspection Date: 2023-04-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1312270 - 2026-04-06](https://www.keypedia.com/records/fda_inspections/south-florida-institute-for-reproductive-medicine/ba9949bf-f0cd-4c93-9d3d-c6140591d164)
- [FDA Inspection 1204459 - 2023-04-19](https://www.keypedia.com/records/fda_inspections/south-florida-institute-for-reproductive-medicine/2ed93622-909e-458a-a6c0-d3d6b8ec167c)
- [FDA Inspection 1151264 - 2021-09-01](https://www.keypedia.com/records/fda_inspections/south-florida-institute-for-reproductive-medicine/369a8acd-275d-4ee1-8415-8e4d1cf07e03)
- [FDA Inspection 1151264 - 2021-09-01](https://www.keypedia.com/records/fda_inspections/south-florida-institute-for-reproductive-medicine/e203d2a2-ff91-42fa-ba3c-0db933d1d756)
- [FDA Inspection 1029066 - 2017-08-07](https://www.keypedia.com/records/fda_inspections/south-florida-institute-for-reproductive-medicine/08958c95-60ec-4128-93de-babf4c0ceed5)

Company: https://www.keypedia.com/companies/south-florida-institute-for-reproductive-medicine/1208373b-05cc-4101-b642-be28d61eabe6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d